Nature Medicine, Published online: 21 August 2026; doi:10.1038/s41591-026-04524-1
A new study offers the first systematic test of whether DNA methylation clocks behave the way a surrogate endpoint for aging should, responding to genuine clinical benefit and remaining stable when there is none.
